Completed PHASE1 INTERVENTIONAL 2-arm NCT00939367

Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Zolpidem Tartrate Tablets Under Fed Conditions

Randomized, Two Period Crossover Studies in Fed Healthy, Normal Subjects to Compare the Single Dose Bioavailability of Torrent's Zolpidem Tartrate Tablets 10 mg and Sanofi-Synthelabo's Ambien® 10 mg Tablets

Sponsor: Torrent Pharmaceuticals Limited

Conditions Healthy

Interventions 'Sanofi-Synthelabo Inc's Ambien® Tablets 10 mg Zolpidem Tartrate Tablets 10 mg

Updated 8 times since 2017 Last updated: May 1, 2018 Started: Feb 24, 2007 Primary completion: May 2, 2007 Completion: May 2, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Healthy, this trial is completed. The trial is conducted by Torrent Pharmaceuticals Limited and has accumulated 8 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2023 — Jul 2024 [monthly]

Completed PHASE1
Dec 2022 — Jan 2023 [monthly]

Completed PHASE1
Jan 2021 — Dec 2022 [monthly]

Completed PHASE1

▶ Show 3 earlier versions

Jul 2018 — Jan 2021 [monthly]

Completed PHASE1
Jun 2018 — Jul 2018 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Feb 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Torrent Pharmaceuticals Limited

Data source: Torrent Pharmaceuticals Limited

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mumbai, India